|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/6874 | |
| C12Q 1/6881 | |||
| C12Q 1/6888 | |||
| A61K 39/00 | |||
| A61K 35/17 | |||
| G06F 19/18 |
| (11) | Number of the document | 2872653 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13817114.5 |
| Date of filing the European patent application | 2013-07-12 | |
| (97) | Date of publication of the European application | 2015-05-20 |
| (45) | Date of publication and mention of the grant of the patent | 2019-03-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/050362 |
| Date | 2013-07-12 |
| (87) | Number | WO 2014/012051 |
| Date | 2014-01-16 |
| (30) | Number | Date | Country code |
| 201261670931 P | 2012-07-12 | US |
| (72) |
VITIELLO, Maria, Antonia, US
|
| (73) |
Persimmune, Inc.,
11555 Sorrento Valley Road, San Diego, CA 92121,
US
|
| (54) | PERSONALIZED CANCER VACCINES AND ADOPTIVE IMMUNE CELL THERAPIES |
| PERSONALIZED CANCER VACCINES AND ADOPTIVE IMMUNE CELL THERAPIES |